Equities Analysts Offer Predictions for Seattle Genetics, Inc.’s Q1 2020 Earnings (NASDAQ:SGEN)
Seattle Genetics, Inc. (NASDAQ:SGEN) – Research analysts at Oppenheimer issued their Q1 2020 earnings per share (EPS) estimates for shares of Seattle Genetics in a research report issued to clients and investors on Thursday, December 12th, according to Zacks Investment Research. Oppenheimer analyst S. Tuerkcan anticipates that the biotechnology company will post earnings per share of ($0.50) for the quarter. Oppenheimer has a “Outperform” rating and a $124.00 price target on the stock. Oppenheimer also issued estimates for Seattle Genetics’ Q2 2020 earnings at ($0.39) EPS and Q3 2020 earnings at ($0.30) EPS.